Alternative and Complementary Medicine at the National Cancer Institute of Colombia: A Prevalence Survey
Keywords:
Complementary therapies, neoplasm, cross-sectional studies, prevalence.Abstract
Objective: To determine use prevalence for alternative and complementary medicines at the National Cancer Institute of Colombia.
Methods: A cross-sectional study was carried out. Focus groups were used for designing the survey.
Results: 359 surveys were carried out corresponding to patients with different types of cancer. In total 38 types of complementary medicines were reported and the median number of therapies per patient was 2. Some 73.5% (95%CI 68.7%-78.0%) used complementary and alternative therapies, being the group of herbal medicine the most commonly used. Doctors recommended their use in 8% of cases. The family and nearby persons were the main source for accessing this type of therapies.
Conclusions: There is a high-frequency utilization of complementary and alternative therapies. The group of herbal medicine is the most common. The findings contradict the lack of access to this type of therapies with in the health system. In our country, additional research is needed in this area.
Author Biographies
Ricardo Sánchez, Instituto Nacional de Cancerología
Grupo de Investigación Clínica, Instituto Nacional de Cancerología. Bogotá, D.C., Colombia
Universidad Nacional de Colombia, Bogotá, D.C., Colombia
Marco Venegas, Instituto Nacional de Cancerología
Grupo de Investigación Clínica, Instituto Nacional de Cancerología. Bogotá, D.C., Colombia.
References
National Center for Complementary and Alternative Medicine. What is Complementary and Alternative Medicine? [internet]. 14 oct. 2009 [citado: 25 feb. 2010]. Disponible en: http://www.nccam.nih.gov/health/whatiscam/.
Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328(4):246-52.
https://doi.org/10.1056/NEJM199301283280406
Medline Plus. Complementary and alternative medicine. [internet]. 19 feb 2010, [citado: 25 feb. 2010]. Disponible en: http://www.nlm.nih.gov/medlineplus/complementaryandalternativemedicine.html
Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004;9(1):80-9.
https://doi.org/10.1634/theoncologist.9-1-80
Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the Unites States, 1990-1997: results of a follow-up national survey. JAMA. 1988;280(18):1569-75.
https://doi.org/10.1001/jama.280.18.1569
Ni H, Simile C, Hardy AM. Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care. 2002;40(4):353-8.
https://doi.org/10.1097/00005650-200204000-00011
Devine P. Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer. 2000;88(3):615-9.
https://doi.org/10.1002/(SICI)1097-0142(20000201)88:3<615::AID-CNCR18>3.0.CO;2-P
Myers C, Stuber ML, Bonamer-Rheingans JI, Zeltzer LK. Complementary therapies and childhood cancer. Cancer Control. 2005;12(3):172-80.
https://doi.org/10.1177/107327480501200305
The University of Texas. M. D. Anderson Cancer Center. Complementary/integrative therapies. [internet]. 2007 (citado: 27 dic. 2009). Disponible en: http://www.mdanderson.org/departments/cimer/dindex.cfm?pn=5ac57a83-0f8d-4a3f-b743a0cdf23f193c.
Sueco Tibaná E, Taschner Goldenstein P, de Melo Ribeiro L, Lewin F, Valesin Filho ÉS, Prado Soares H, et al. Praying correlates with higher quality of life: results from a survey on complementary/alternative medicine use among a group of Brazilian cancer patients. Sao Paulo Med J. 2004;122(2):60-3.
https://doi.org/10.1590/S1516-31802004000200005
Penson RT, Partridge RA, Rudd P, Seiden MV, Nelson JE, Chabner BA, et al. Laughter: the best medicine? Oncologist. 2005;10(8):651-60.
https://doi.org/10.1634/theoncologist.10-8-651
University of California Medical Center. National Center for Complementary and Alternative Medicine. Classification of Alternative Therapies. [internet]. 19 feb. 2010 [citado: 25 feb. 2010]. Disponible en: http://cancer.ucsd.edu/Outreach/PublicEducation/CAMs/appendixa.asp.
NIH Consensus Conference. Acupuncture. JAMA. 1998;280(17):1518-24.
https://doi.org/10.1001/jama.280.17.1518
Elias MC, Alves E. [Non-conventional medicine: prevalence in oncologic patients]. Rev Bras Cancerol. 2002;48(4):523- 32. Portuguese.
Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505-14.
https://doi.org/10.1200/JCO.2000.18.13.2505
Cassileth BR. Complementary therapies: the American experience. Support Care Cancer. 2000;8(1):16-23.
https://doi.org/10.1007/s005209900036
Sagar SM. Acupuncture as an evidence-based option for symptom control in cancer patients. Curr Treat Options Oncol. 2008;9(2-3):117-26.
https://doi.org/10.1007/s11864-008-0063-3
Naeim A, Dy SM, Lorenz KA, Sanati H, Walling A, Asch SM. Evidence-based recommendations for cancer nausea and vomiting. J Clin Oncol. 2008;26(23):3903-10. Review.
https://doi.org/10.1200/JCO.2007.15.9533
Chiu J, Yau T, Epstein RJ. Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers. Support Care Cancer. 2009;17(3):231-40.
https://doi.org/10.1007/s00520-008-0526-x
McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer. 2004;12(6):454-62.
https://doi.org/10.1007/s00520-004-0598-1
Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Spareboom A. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst. 2002;94(16):1247-9.
https://doi.org/10.1093/jnci/94.16.1247
D'Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin. 2005;55(5):319-21.
https://doi.org/10.3322/canjclin.55.5.319
Bourgeault IL. Physicians' attitudes toward patients' use of alternative cancer therapies. CMAJ. 1996;155(12):1679- 85.
Ukiya M, Akihisa T, Yasukawa K, Tokuda H, Suzuki T, Kimura Y. Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers. J Nat Prod. 2006;69(12):1692-6.
https://doi.org/10.1021/np068016b
Ulbricht C, Armstrong J, Basch E, Basch S, Bent S, Dacey C, et al. An evidence-based systematic review of Aloe vera by the natural standard research collaboration. J Herb Pharmacother. 2007;7(3-4):279-323.
https://doi.org/10.1080/15228940802153339
Furusawa E, Hirazumi A, Story S, Jensen J. Antitumour potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) on sarcoma 180 ascites tumour in mice. Phytother Res. 2003;17(10):1158-64.
https://doi.org/10.1002/ptr.1307
Liu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res. 2001;61(15):5749-56.
Pilarski R, Poczekaj-Kostrzewska M, Ciesiołka D, Szyfter K, Gulewicz K. Antiproliferative activity of various Uncaria tomentosa preparations on HL-60 promyelocytic leukemia cells. Pharmacol Rep. 2007;59(5):565-72.
Styczynski J, Wysocki M. Alternative medicine remedies might stimulate viability of leukemic cells. Pediatr Blood Cancer. 2006;46(1):94-8.
https://doi.org/10.1002/pbc.20513
Vickers AJ. How to design a phase I trial of an anticancer botanical. J Soc Integr Oncol. 2006;4(1):46-51.
Chung VQ, Tattersall M, Cheung HT. Interactions of a herbal combination that inhibits growth of prostate cancer cells. Cancer Chemother Pharmacol. 2004;53(5):384-90.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Todos los derechos reservados.
